FROM COMPLIANCE TO QUALITY EXCELLENCE: NAVIGATING THE 13 PARTS OF INDIA’S REVISED SCHEDULE M UNDER UPDATED CDSCO GMP GUIDELINES

Good Manufacturing Practices play a critical role in ensuring that pharmaceutical products are manufactured consistently and meet required standards, safety, efficacy, and quality. In India, these standards are regulated through Schedule M of the Drugs and Cosmetics Rules, which establishes guidelines for pharmaceutical manufacturing facilities, quality systems, documentation practices, and regulatory compliance. The recently revised Schedule M introduces a stronger focus on the Pharmaceutical Quality System, risk management, validation, and continuous quality improvement to align Indian manufacturing practices with global GMP expectations. This review article explores the structure and significance of the 13 parts of the revised Schedule M and their contribution to strengthening pharmaceutical manufacturing standards in India. Particular emphasis is placed on essential GMP elements such as documentation systems, personnel training, facility design, validation, quality control, complaint handling, product recall procedures, and self-inspection mechanisms. The article also highlights the increasing role of digital technologies, including electronic documentation systems and audit trails, which support data integrity and regulatory transparency. By integrating global quality principles with national regulatory requirements, the revised Schedule M supports the development of a more robust pharmaceutical quality framework that enhances product reliability, regulatory compliance, and international acceptance of medicines manufactured in India.

• Wasiullah M, Yadav P, Yadav P, Deepak VK. A review on role of GMP in pharmaceutical industry and their benefits. World Journal of Pharmaceutical Research, 2022 Nov 12; 12(1): 298-311.
• Alili Idrizi E, Ahmeti Lika S, Bexheti D, Dauti M, Janevik-Ivanovska E. Quality Audits-Viewpoints of Auditing in the Pharmaceutical Industry. The Albanian Journal of Medical and Health Sciences, 2022; 60: 1-2.
• Kumar S, Tanwar D, Arora N. The role of regulatory GMP audit in pharmaceutical companies. Int J Res Dev Pharm Life Sci., 2013; 2: 493-8.
• Kaur J. Quality audit: Introduction, types and procedure. Place Unknown: Pharma Pathway; 2017. Available from: http://pharmapathway.com/quality-audit-introduction-types-and-procedure/.
• Biswas P. ISO 9001. Internal audit [Internet]. Place Unknown: Word Press; 2015. Available from: http://isoconsultantpune.com/iso 90012015-internal-auditby-pretesh-biswas-apb consultant/.
• Chingale ND, Walunj SD, Kikale MS, Devade OA, Redasani V. DOCUMENTATION ESSENTIALS IN THE PHARMACEUTICAL INDUSTRY: A REGULATORY PERSPECTIVE.
• Natascia Meneghetti, Pierantonio Facco, F. Bezzo. "Knowledge management in secondary pharmaceutical manufacturing by mining of data historians-A proof-of-concept study." International Journal of Pharmaceutics, Volume, 2016; 505, 1-2: 394-408.
• Kurniawan MA, Khairullah AR, Puspitasari Y, Nifa FH, Ahmad RZ, Pratama BP, Tyasningsih W, Kurniasih DA, Raharjo HM, Moses IB, Wardhani BW. Cross-contamination risks and hazard analysis and critical control point (HACCP) strategies in the meat industry: A Review. Journal of Advanced Veterinary Research, 2026 Jan 1; 16(2): 292-300.
• Possas, A., Perez-Rodriguez, F., 2023. New Insights into Cross-Contamination of Fresh-Produce. Curr. Opin. Food Sci., 49: 100954. doi: 10.1016/j.cofs.2022.100954.
• Shiihi S, Okafor UG, Ekeocha Z, Byrn S, Clase K. Improving the outcome of GMP inspections by improving proficiency of inspectors through consistent GMP trainings.
• Tomić, S., Sučić, A., & Martinac, A. (2010). Good manufacturing practice: The role of local manufacturers and competent authorities. Archives of Industrial Hygiene and Toxicology, 61(4):       425–436.
• Madanayake SN, Manipura A, Thakuria R and Adassooriya NM: Opportunities and challenges in mechanochemical cocrys-tallization toward scaled-up pharmaceutical manufacturing. Organic Process Research & Development, 2023; 27(3): 409-22.
• Dey S, Dutta S and Ray J: A review article on an existing schedule m vs revised schedule M. Int J Pharm Sci & Res., 2025; 16(3): 663-69. doi: 10.13040/IJPSR.0975- 8232.16(3).663-69.
• Mishra L and Kurmi BD: Cosmetics regulations and standardization guidelines. Pharmaspire, 2023; 15: 137 50.
• Dey S, Dutta S, Ray J. A REVIEW ARTICLE ON AN EXISTING SCHEDULE M VS REVISED SCHEDULE M.
• Suamte L, Tirkey A, Barman J and Babu PJ: Various manufacturing methods and ideal properties of scaffolds for tissue engineering applications. Smart Materials in Manufacturing, 2023; 1: 100011.
• Pocatilu P and Vetrici M: Schedule risk management for business M-applications development projects. WSEAS Transactions on Computers, 2009; 8(4): 735-45. 11. 
• Weaver E, O’Hagan C and Lamprou DA: The sustainability of emerging technologies for use in pharmaceutical manufacturing. Expert Opinion on Drug Delivery, 2022; 19(7): 861-72.
• Souto EB, Silva GF, Dias-Ferreira J, Zielinska A, Ventura F, Durazzo A, Lucarini M, Novellino E and Santini A: Nanopharmaceutics: Part I—Clinical trials legislation and good manufacturing practices (GMP) of nanotherapeutics in the EU. Pharmaceutics, 2020; 12(2): 146.
• Barshikar R: Covid 19–Impact and new normal for pharmaceutical industry (Part–I). Journal of Generic Medicines, 2020; 16(3): 112-9.
• Weaver, Edward, Collette O’Hagan, and Dimitrios A. Lamprou. "The sustainability of emerging technologies for use in pharmaceutical manufacturing." Expert Opinion on Drug Delivery, 2022; 19(7): 861-872.
• Weaver E, O’Hagan C and Lamprou DA: The sustainability of emerging technologies for use in pharmaceutical manufacturing. Expert Opinion on Drug Delivery, 2022; 19(7): 861-72.
• Central Drugs Standard Control Organization. Revised Schedule M under Drugs and Cosmetics Rules, 1945. Ministry of Health and Family Welfare, Government of India, 2023.
• Gorukanti P, Jogala S, Boggula N, Makula S. Good Manufacturing Practices and Documentation in Pharmaceutical Production: A Comprehensive Review. Asian Journal of Pharmaceutical Research and Development, 2025 Dec 15; 13(6): 86-95.
• Qualityze. Different Types of Batch Records in Pharmaceutical Industry. Quality Management Documentation Guide, 2025. 
• 10. ValGenesis. Six Best Practices for ALCOA Data Integrity Success. GMP Compliance Blog, 2024.
• Patil SD, Raut MK, Rathod NP. Quality Control And Quality Assurance In Pharmaceuticals. Int. J. in Pharm. Sci., 2023; 1: 91.
• Pooja Rajan, P. Sindhuja, M. V. Nagabhushanam, Brahmaiah Bonthagarala, D. Nagarjuna Reddy and G. Ramakrishna; A Review on In processes and Finished Products Quality Control Test for tablets according to Pharmacopoeias; World Journal of Pharmacy and Pharmaceutical Sciences; page no.306 – 307.
• Aher SN, Sonawane GB, Sonawane VN, Gunjal PA, Bacchav JB. DIGITAL DOCUMENTATION IN MODERN PHARMACEUTICAL QUALITY ASSURANCE: A STRATEGIC REVIEW. Pharmaceutical Research, 14(22): 58-72.
• Mazan KD. FDA's Electronic Records and Electronic Signatures Rule: Structuring a Risk-Based Approach. FDLI Update, 2003; 12.
• Burcham RL. INTRODUCTION TO FDA 21 CFR PART 11. The Pharmaceutical Regulatory Process, 2008 Dec 2; 429. 24.
• U.S. Food and Drug Administration. 21 CFR Part 11 – Electronic Records; Electronic Signatures. Silver Spring (MD): FDA, 2003.
• Bchkol DH, Abdulkareem AH, Habib FA. A Study on Quality Control Tests for Dosage Forms and their Effect on Physical, Chemical and Biological Specifications: A Review.
• JM Fortunak1; RD Souza; AA Kulkarni; CL King; T Ellison; LSM Miranda, Antivi. Thera., 2014; 19(3): 4-6.
• T Mehmood; MR Salaria; GM Herani; MA Qureshi, Ind. J. of Manage. & Soci. Sci., 2009; 3(2): 21-30.
• https://drugscontrol.py.gov.in/sites/default/files/2024-08/G.S.R.%20922%28E%29.pdf
• Becker J, Manske C and Randl S: Green chemistry and sustainability metrics in the pharmaceutical manufacturing sector. Current Opinion in Green and Sustainable Chemistry, 2022; 33: 100562.
• Ahmed S, Islam S, Ullah B, Biswas SK, Azad AS and Hossain S: A review article on pharmaceutical analysis of pharmaceutical industry according to pharmacopoeias. Oriental Journal of Chemistry, 2020; 36(1).
• Kumar A, Yadav DK, Kumar M, Alam T, Subramanyam S. Good Manufacturing Practices (Gmp) And Regulatory Challenges In The Pharmaceutical Industry: A Comprehensive Review.
• Jena S., Arjun G., Ravipati A. K., kumar D. S., Vinod K. R., David B., Industrial process validation of solid dosage forms – an overview. International Journal of Pharmaceutical Sciences Review and Research, 2010; 4(2): 145-154.
• Singh SP, Dhaker K, Namdev A, Khinchi MP, Bhatnagar S. A Review on Process Validation. PharmaTutor., 2016; 4(12): 9–19.
• Sharma PP. Validation in Pharmaceutical Industry. 6th ed. United Kingdom: Informa Healthcare Publication, 2016; 51-70.
• GMP Inspections | Medicines for Human Use. (2017). HPRA. Available online at: https://www.hpra.ie/regulation/human-medicine/manufacturers/good-manufacturing-practice (gmp)-inspections (Accessed March 4, 2025) Google Scholar.
• Alili Idrizi E, Ahmeti Lika S, Bexheti D, Dauti M, Janevik-Ivanovska E. Quality Audits-Viewpoints of Auditing in the Pharmaceutical Industry. The Albanian Journal of Medical and Health Sciences, 2022; 60: 1-2.
• Biswas P. ISO 9001. Internal audit [Internet]. Place Unknown: Word Press; 2015. Available from: http://isoconsultantpune.com/iso 90012015-internal-auditby-pretesh-biswas-apb consultant/.
• Tawade M, Pandya S, Scholar PG. Optimizing pharmaceutical quality audits: Enhancing compliance and performance through best practices. Journal for New Zealand Herpetology, 2023; 12(3): 6514-22.
• Linna A, Korhonen M, Mannermaa JP, Airaksinen M, Juppo AM. Developing a tool for the preparation of GMP audit of pharmaceutical contract manufacturer. European Journal of Pharmaceutics and Biopharmaceutics, 2008 Jun 1; 69(2): 786-92.
• Agarwal PR, Mishra AM. Pharmaceutical quality audits a review. Int J Appl Pharm., 2019; 11: 14-22.
• https://cdsco.gov.in/opencms/opencms/en/About-us/Introduction/
• Ahmed, S, Kundu, S, Patra, R, and Ray, J. Change control from initiation to implementation in the pharmaceutical industry: a comprehensive review. Int J Res Pharm Sci., 2024; 15: 21–33. doi: 10.26452/ijrps.v15i3.4681Crossref Full Text | Google Scholar
• Jena S., Arjun G., Ravipati A. K., kumar D. S., Vinod K. R., David B., Industrial process validation of solid dosage forms – an overview. International Journal of Pharmaceutical Sciences Review and Research, 2010; 4(2): 145-154.
• Quality Management System – Process Validation Guidance GHTF/SG3/N99-10:2004 (Edition 2)
• Waghmare YS, Mahaparale SP. The important role of technology transfer in pharmaceutical industry-a review. World Journal of Pharmaceutics Research, 2017 Jun 28; 6(9): 310-29.
• Ortega AJ, Arce NA, Sequeda F, Gribenchenko I. Management of Innovation and Technology transfer process between University and Industry. The Mater Res Cent Case, 2009; 2: 7-8.